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Abstract 
Noise exposure has become a part of everyday life, but over exposure to loud daily noise 
may result in irreversible noise-induced hearing loss (NIHL). NIHL is a result of damage to the 
outer hair cells (OHCs) and spiral ganglion neurons (SGNs) of the cochlea- the key inner ear 
structures responsible for the sense of hearing. Currently, there are several diagnostic tests that 
are capable of detecting damage to the OHCs; however, no test exists that can detect damage or 
loss of SGNs. It would be desirable to have a diagnostic test to detect such damage due to the 
distortion effect that SGN loss can have on sound stimuli such as speech. The purpose of this 
study is to begin developing a diagnostic test that could be used to detect the damage or loss of 
SGNs over the 30-60 years of the typical span of adulthood. For the test to be viable for clinical 
use, it needs to be stable and consistent from one test session to the next. For the current project, 
every 4 weeks for a 24-week duration, the electrocochleography (EcochG) and Auditory 
Brainstem Response (ABR) of 7 rat subjects were measured and different components (the 
cochlear microphonic (CM and ABR Wave V) were analyzed to assess the health of the SGNs. 
Our results showed that the CM-ABR Wave V ratios were statistically unchanged at each of the 
monthly test times. Such a finding would mean that there is the possibility that the testing could 
be used to assess damage or loss of SGNs in the noise-exposed human population without 
concern that changes detected in the test are due to random fluctuations that occur between 
testing sessions. 
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Introduction 
Noise has become part of everyday life in industrial America, and many people disregard 
or ignore the daily noises to which they are exposed. However, as harmless as these sounds may 
seem, it is important to understand the irreversible damage that can be caused by over exposure 
to intense noise. Every day, around 30 million Americans are exposed to noise levels considered 
to be at a dangerous level, while 10 million Americans suffer from irreversible noise-induced 
hearing loss (NIHL) (ASHA, 2013). These dangerous exposures can come from the most 
obvious causes of occupational noise: factory work, construction work, military use of firearms 
and explosives, etc.  But dangerous exposures can occur from other, more subtle, sources: 
portable music players, traffic noise, power tools, etc.  Without proper hearing protection, this 
over-exposure to noise at dangerous levels can result in permanent hearing loss due to 
destruction of the inner ear structures. 
 The inner ear structure responsible for the sense of hearing is the cochlea.  The cochlea is 
a complex structure with numerous unique cell populations that combine to transduce sound 
signals into the electro-chemical communication of the nervous system.  Within the cochlea, the 
two structures most heavily damaged by noise exposure are the outer hair cells (OHCs) 
(Henderson et al., 2006) and the spiral ganglion neurons (SGNs) (Kujawa and Liberman, 2006; 
2009; Lin et al., 2011).  There are several tests that can detect noise-induced OHC loss, including 
otoacoustic emissions and the puretone audiogram; however, no current testing is available to 
detect damage or loss of SGNs.  A reliable test to determine SGN damage would be of great use 
for diagnosing the nature of an individual patient’s NIHL.  Loss of OHCs leads to a predictable 
and consistent series of hearing deficits, most notably a threshold shift to pure tonal sounds that 
can be easily assessed with a standard clinical audiogram.  With damage to the SGNs, the impact 
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on hearing sensitivity is much more subtle.  There can be massive damage to the SGNs without a 
significant change in pure tone thresholds on the audiogram, as evidenced by children with 
auditory neuropathy spectrum disorder (Starr et al., 1996).  Processing of complex sounds, such 
as speech, and the ability to hear in background noise are slowly diminished in patients with 
SGN loss.  Speech discrimination testing is an effective means of identifying patients in whom 
the SGNs are damaged, but the diagnostic challenge lies in the fact that there needs to be a 
considerable amount of damage to the SGNs before there are noticeable changes in speech 
discrimination ability.  Therefore, by the time a diagnosis of probable SGN impairment can be 
made, the damage is often too severe for any effective treatment option to be considered.  Further 
complicating the issue is that SGN damage has been shown to occur in animal models after noise 
exposures that had previously been believed to be non-hazardous (Kujawa and Liberman, 2006; 
2009).  Therefore, there may be a population of human patients who are experiencing SGN 
damage due to noise they believe to be non-hazardous, and there is currently no way to detect 
SGN damage before there is massive cell loss and significant resultant hearing impairment.  
Development of testing to identify SGN damage could further add to the understanding and 
solution of these individuals’ problems.   
The current study assessed the long-term stability of the ratio of the cochlear microphonic 
(CM) to Wave V of the auditory brainstem response (ABR).  The CM is an electrophysiologic 
response derived from the responses of the outer hair cells, while Wave V of the ABR is a 
central auditory response generated by the lateral lemniscus and/or inferior colliculus of the 
central auditory nervous system.  The underlying logic for creating a ratio of those two potentials 
is that the CM is immune to changes in the SGNs, while Wave V of the ABR will be reduced by 
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loss of input from the SGNs.  Therefore, in cases of SGN loss, the CM-Wave V ratio should 
increase. 
Materials and Methods 
Auditory Evoked Potentials (AEPs) are measurements of nerve and/or muscle activity 
after the presentation of an auditory stimulus (Jewett and Williston, 1971). AEPs can be 
subdivided into tests based on latency of responses; these subdivisions are: Electrocochleography 
(EcochG), Auditory Brain Stem Response (ABR), Auditory Middle Latency Response (MLR), 
and Auditory Late Responses (ALR) (Martin & Clark, 2012).  The current project focused on 
one component of EcochG; the CM.  The other response analyzed was the ABR Wave V.  
The CM is a measurement of the receptor potentials of the OHCs (Hall, 2007) and is used to 
measure the displacement action of the basilar membrane (Yost, 2008).  The ABR Wave V is the 
largest of the brainstem auditory evoked potentials and reflects activation of the lateral lemniscus 
and inferior colliculus (Hall, 2007).  By combining these tests in a novel way, the goal was to be 
able to more specifically identify the locations of pathologies involved in hearing loss in relation 
to the spiral ganglion.  These tests will help us assess the afferent pathways – pathways that carry 
impulses from periphery towards the nervous system (Martin & Clark, 2012), from the cochlea 
to the brain.   
Importantly, the CM and ABR Wave V components have a directly proportional 
relationship between amplitude and intensity; this means that as the stimulus intensity increases, 
the amplitudes of the CM or ABR Wave V also increase.  In conditions in which the SGNs are 
lost or damaged, the ABR Wave V amplitudes will be depressed due to a lack of cells 
contributing to the response.  The CM is immune to changes in the SGNs, since it is a reflection 
of the OHC receptor potentials.  Therefore, in conditions of SGN degeneration, the CM will 
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remain stable and the ABR Wave V will decline.  The CM- ABR Wave V ratio will increase.  
Including the CM in conjunction with the ABR Wave V will allow more precise measurements 
of SGN decay to be made, without concern about test/re-test reliability.   
In this experiment, 7 Fischer 344/NHsd normal hearing rats were tested.  The animals’ 
CM and ABR Wave V responses were recorded every 4 weeks.  Although the term “ABR Wave 
V” is used here, that is a term derived from the human ABR.  In the human ABR the largest 
wave, the one generated by the lateral lemniscus and inferior colliculus, is the fifth wave in the 
ABR complex.  In the rat, it is the second wave in the complex, with the first wave being the 
compound action potential (CAP, See Figure 1).  The term “ABR Wave V” is used in this 
experiment to connect it to the human ABR.  The goal of the current study is to establish norms 
for this combination of tests and assess the test’s reliability from month to month. This 
progression of testing will hopefully add to the knowledge of the relationship between the CM 
and ABR Wave V, along with supporting our search for testing that can specify particular cell 
pathologies (particular to the SGNs) that are related to hearing loss.   
The 7 animals were anesthetized using inhalant isoflurane (4% for induction, 1.5% for 
maintenance, 1L/min 𝑂2 flow rate). Sub-dermal platinum needle electrodes were used to record 
responses and were placed behind the contralateral pinna (non-inverting), behind the ipsilateral 
pinna (inverting) and behind the shoulder blade (ground). Toneburst stimuli were used at 
frequencies of 5, 10, 15, 20, and 30 kHz and responses were recorded. The stimuli were 
delivered from a speaker positioned 3 inches from the test ear of each animal. These acoustic 
stimuli were calibrated before each testing and BioSig RZ programing was used for data 
collection. Each toneburst had a duration of 1 ms with a 0.5 ms rise/fall time with no plateau. 
The signal level was decreased in 5dB steps beginning at 100 dB SPL and decreasing to 0 dB 
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SPL. The amplitudes of the CM and ABR Wave V were measured by cursoring the highest peak 
of each wave and the lowest negative trough after that peak (see Figure 1). A two-factor 
ANOVA (time x stimulus level) was used to analyze the ABR thresholds across the 7 animals 
and across the 6 different test stimuli. 
Predicted Results:  
With the current experiment, the goal was to establish whether the ratio of the CM and 
ABR Wave V, across multiple stimulus intensity levels and frequencies, is consistent over time.  
Hypothetically, if there were differences in the recording parameters from test to test (due to 
electrode placement or impedance, or depth of animals’ anesthetic states) those differences 
should have affected the CM and ABR Wave V equally, and the CM-ABR Wave V ratio should 
have remained stable.  Therefore, our predicted result was that the CM-ABR Wave V ratios 
would be statistically indistinguishable from each other at each of the monthly test times.  If 
there was significant instability in the CM-ABR Wave V amplitude ratios over multiple tests, 
there is no future for this novel design in diagnostic testing for those with hearing loss.  
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Figure 1: Example response waveform from a Fischer 344/NHsd normal hearing rat elicited 
from a 5 kHz stimulus at 90 dB SPL.   ABR Wave V amplitude in this example was 
calculated by subtracting the amplitude of cursor VI from the amplitude of cursor V to 
calculate peak-to-peak amplitude. 
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Results 
 ABR Wave V amplitudes at each of the frequencies are displayed in Figures 2 through 6 
showing the amplitudes of ABR Wave V responses over the 24 week period to the stimuli from 
30 dB SPL to 100 dB SPL.  Levels below 30 dB SPL were excluded from the analyses because 
few animals had consistent responses at those low levels.  At each frequency (5, 10, 15, 20, and 
30 kHz), there were no statistically significant differences in the ABR Wave V amplitudes from 
week to week.   
 Next, the CM-ABR Wave V ratios were assessed from week to week.  Notice, only 3 
frequencies (5, 10, 15 kHz ) were assessed for this ratio. That is because the CM response 
disappeared or was too small to record at the 20 and 30 kHz levels. In Figures 7 through 9 the 
CM-ABR Wave V ratios are graphed displaying the results from week 0 to week 24. For this 
ratio response, there were no significant differences from month to month.  There was a 
significant week x level interaction detected for the 5 kHz stimulus in which the Week 8 
recording was significantly lower than the other weeks at 80 and 85 dB SPL 
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Figure 2: ABR Wave V amplitude input-output functions for the 5 kHz stimulus. No statistically 
significant differences between test weeks were detected. 
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Figure 3: ABR Wave V amplitude input-output functions for the 10 kHz stimulus. No statistically 
significant differences between test weeks were detected. 
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Figure 4: ABR Wave V amplitude input-output functions for the 15 kHz stimulus. No statistically 
significant differences between test weeks were detected. 
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Figure 5: ABR Wave V amplitude input-output functions for the 20 kHz stimulus. No statistically 
significant differences between test weeks were detected. 
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Figure 6: ABR Wave V amplitude input-output functions for the 30 kHz stimulus. No 
statistically significant differences between test weeks were detected. 
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Figure 7: CM-ABR Wave V amplitude ratio input-output functions for the 5 kHz stimulus. A 
significant week x level interaction was detected, and Week 8 was lower than the other tests at 
80 and 85 dB SPL. 
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Figure 8: CM-ABR Wave V amplitude ratio input-output functions for the 10 kHz stimulus. No 
statistically significant differences between test weeks were detected. 
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Figure 9: CM-ABR Wave V amplitude ratio input-output functions for the 15 kHz stimulus. No 
statistically significant differences between test weeks were detected. 
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Discussion 
 The results of this study indicate that the predicted result that the tests would be 
statistically indistinguishable from month to month was indeed correct.  This conclusion can be 
drawn because the animals’ Wave V amplitudes and CM-Wave V ratios did not change with any 
significance over the testing times.  There was a change in the 5 kHz CM-Wave V ratio result at 
Week 8 at two stimulus intensity levels, but these changes did not persist over any of the test 
points thereafter.  This indicates that those changes were simply an anomaly of that particular 
test point.  The general stability of these measures over time indicates that there is a good test-re-
test reliability with these particular assessments. Good reliability is crucial for potential clinical 
use for testing in individual patients with cochlear damage, and this study indicated that these 
assessments may be useful clinically if they do prove to be sensitive to SGN damage.  
 The presence of the statistically-significant changes at the Week 8 time point does 
indicate that the test is susceptible to some random fluctuations.  This would indicate that if the 
test is to be used in individual patients who have been exposed to noise, the test should be 
repeated at regular intervals before a firm diagnosis can be made.  The test’s ideal use is as a 
monitoring test for patients who experience noise exposure in the workplace or recreationally.  
The stability of the test seen in the current study is an indication that with repeated tests over 
time, those without SGN damage will be correctly identified as normal if a pre-exposure 
measurement has been taken, or comprehensive normative data can be acquired. 
 What is unknown from the current test is how the CM-Wave V ratio responds to noise 
exposures.  That question is being addressed in other experiments. We hypothesize that in such 
experiments the CM-ABR Wave V ratios will increase in a noise-exposed population.  This 
increase in the CM-ABR Wave V ratio will be the result of cochlear de-afferentation.  The 
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current study might have benefitted from more animals being tested instead of the seven used in 
the study.  In general, the variances were relatively low, indicating that more animals and greater 
statistical power would not have revealed any differences between test times. 
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